by Amy Berger | Mar 22, 2023 | Blog, News
The recent outbreaks of pan-resistant Candida auris and the alarming effects on health care facilities have brought to the forefront the challenges of combating drug-resistant pathogens. The typical treatment for Candida infections and most C. auris infections are...
by Amy Berger | Dec 22, 2022 | Blog, News
IITRI is proud to share recent accomplishments from two of our technical divisions. Several members of our Microbiology and Molecular Biology Division authored a recent publication entitled “Characterization of Three Variants of SARS-CoV-2 In Vivo Shows...
by Amy Berger | Oct 26, 2022 | Blog, Events
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. They just announced the Investigational New Drug (IND) application of ASC10, an oral antiviral drug candidate targeting viral polymerase of monkeypox virus, has been filed with...
by Amy Berger | Jun 15, 2022 | Blog, Events
We’re excited to be back attending conferences regularly! Next month, we’ll be in Madison, WI for the 41st Annual Meeting of the American Society for Virology. The exhibition runs Sunday July 17 through Tuesday July 19th from 10:30am- 2pm local time in the...
by Amy Berger | Apr 19, 2022 | Blog, News
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. Our team here at IITRI was contracted to perform in vitro testing of their drug candidates for antiviral effects against multiple strains of SARS-CoV-2 as well as cytotoxicity....
by Amy Berger | Aug 24, 2021 | Blog, News
August is National Immunization Awareness Month (NIAM) which serves as reminder of the importance of vaccination for people of all ages. We’re proud to play a role in the development and testing of vaccines here at IITRI. IITRI has decades of experience...
Recent Comments